EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment

Lixuan Yang iD, Lin Li, Jianchun Mao, Qianqian Liang iD

British Journal of Dermatology · 2026

DOI: 10.1093/bjd/ljag258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Dermatology, 2026. Verfasst von Lixuan Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Skin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 143 Literaturangaben. Gefördert von: Xuhui District Famous Traditional Chinese Medicine Physician Studio Construction Project of Shanghai, East China Regional and Municipal TCM Specialty and Disease Alliances, Shanghai Municipal Health Commission - Innovation Team Category.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by skin and internal organ fibrosis, vasculopathy and immune dysregulation. Skin fibrosis, commonly assessed using the modified Rodnan skin score (mRSS), remains a defining feature of SSc and is associated with disease severity and prognosis. However, conventional clinical assessment provides limited insight into the molecular heterogeneity underlying cutaneous involvement. Single-cell RNA sequencing and spatial transcriptomics have shown that SSc skin contains distinct fibroblast states, immune–stromal interactions and spatially organized fibrotic niches. These data challenge the view of cutaneous fibrosis as a uniform process and instead support a model in which different cellular and spatial programmes may contribute to clinically similar patterns of skin involvement. In this review, we synthesize the findings from single-cell and spatial multi-omics studies of SSc skin published between 2021 and 2025, examine the extent to which molecular heterogeneity relates to clinical phenotype, and discuss the implications for cutaneous assessment, treatment response heterogeneity and biologically informed patient subgrouping. Because skin biopsy is clinically accessible and can be repeated over time, it provides a practical setting in which these molecular observations can be studied. Whether they improve patient stratification, treatment selection or cutaneous outcome assessment will depend on prospective validation in larger and clinically well-characterized cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicSkinHumansSpatial TranscriptomicsFibrosisSingle-Cell AnalysisMultiomicsSingle-Cell Gene Expression Analysis

Autor:innen und Institutionen

  • Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Key Laboratory of Ministry of Education of Theory and Therapy of Muscles and Bones, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Wuhua Lilin Clinic, Kunming, China.
  • Department of Rheumatology and Immunology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Lixuan Yang, Qianqian Liang

Förderung

  • Xuhui District Famous Traditional Chinese Medicine Physician Studio Construction Project of Shanghai
  • East China Regional and Municipal TCM Specialty and Disease Alliances
  • Shanghai Municipal Health Commission - Innovation Team Category
  • Shanghai Municipal Health Commission – Innovation Team Category

Zitieren

APA

Yang, L., Li, L., Mao, J., & Liang, Q. (2026). Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag258

Vancouver

Yang L, Li L, Mao J, Liang Q. Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment. British Journal of Dermatology. 2026. doi:10.1093/bjd/ljag258

BibTeX
@article{Yang2026,
  author = {Yang, Lixuan and Li, Lin and Mao, Jianchun and Liang, Qianqian},
  title = {Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment},
  journal = {British Journal of Dermatology},
  year = {2026},
  doi = {10.1093/bjd/ljag258}
}
Kostenlos starten →